| A. Evidence of
effectiveness and ineffectiveness of public health vaccination
strategies. |
|
1. Anthrax (Bacillus anthracis)
|
|
|
Abstract |
Use of anthrax vaccine in the United States. MMWR
Recomm.Rep. 2000; 49: 1-20. |
|
|
Abstract |
Anthrax as a biological weapon: medical and public health
management. Working Group on Civilian Biodefense. Inglesby
TV, Henderson DA, Bartlett JG, et al. JAMA 1999; 281:
1735-1745. |
|
|
Abstract |
Chronic multisymptom illness affecting Air Force veterans
of the Gulf War. Fukuda K, Nisenbaum R, Stewart G, et al. JAMA
1998; 280: 981-988. |
|
|
Abstract |
Repeated immunization: possible adverse effects.
Reevaluation of human subjects at 25 years. White CS, III,
Adler WH, McGann VG. Ann.Intern.Med. 1974; 81:
594-600. |
|
2. Bacterial Meningitis (Neisseria meningitidis)
|
|
|
Abstract |
Control and prevention of meningococcal disease:
recommendations of the Advisory Committee on Immunization
Practices (ACIP). CDC. MMWR Recomm.Rep. 1997; 46:
1-10. |
|
3.
Diphtheria-Tetanus-Pertussis (DTP) and Haemophilus influenzae
type B (Hib) conjugate vaccine
|
|
|
Abstract |
Summary of Notifiable Diseases, United States, 1999. CDC.
MMWR Morb.Mortal.Wkly.Rep. 2001; 48: 1-104. |
|
|
Abstract |
The risk of seizures after receipt of whole-cell pertussis
or measles, mumps, and rubella vaccine. Barlow WE, Davis
RL, Glasser JW, et al. N.Engl.J Med. 2001; 345:
656-661. |
|
|
Abstract |
Effects of diphtheria-tetanus-pertussis or tetanus
vaccination on allergies and allergy-related respiratory
symptoms among children and adolescents in the United States. Hurwitz
EL, Morgenstern H. J Manipulative Physiol Ther. 2000;
23: 81-90. |
|
|
Abstract |
Pertussis vaccination and wheezing illnesses in young
children: prospective cohort study. The Longitudinal Study of
Pregnancy and Childhood Team. Henderson J, North K,
Griffiths M, et al. BMJ 1999; 318: 1173-1176. |
|
|
Abstract |
Tetanus surveillance--United States, 1995-1997. Bardenheier
B, Prevots DR, Khetsuriani N, et al. Mor
Mortal.Wkly.Rep.CDC Surveill Summ. 1998; 47: 1-13. |
|
|
Abstract |
Neonatal tetanus--Montana, 1998. MMWR
Morb.Mortal.Wkly.Rep. 1998; 47: 928-930. |
|
|
Abstract |
Haemophilus influenzae invasive disease among children aged
<5 years-- California, 1990-1996. MMWR
Morb.Mortal.Wkly.Rep. 1998; 47: 737-740. |
|
|
Abstract |
Pertussis costs US population dear. Moore P. Lancet
1997; 349: 405. |
|
|
Abstract |
Pertussis immunization: An update. Morgan LG. J Can
Chiropr Assoc 1997; 41: 86-90. |
|
|
Abstract |
Update: diphtheria epidemic--New Independent States of the Former
Soviet Union, January 1995-March 1996. MMWR
Morb.Mortal.Wkly.Rep. 1996; 45: 693-697. |
|
|
Abstract |
Progress toward elimination of neonatal tetanus--Egypt,
1988-1994. MMWR Morb.Mortal.Wkly.Rep. 1996; 45:
89-92. |
|
|
Abstract |
Food and Drug Administration approval of an acellular
pertussis vaccine for the initial four doses of the
diphtheria, tetanus, and pertussis vaccination series. MMWR
Morb.Mortal.Wkly.Rep. 1996; 45: 676-677. |
|
|
Abstract |
FDA approval of a Haemophilus b Conjugate Vaccine combined
by reconstitution with an acellular pertussis vaccine. MMWR
Morb.Mortal.Wkly.Rep. 1996; 45: 993-995. |
|
|
Abstract |
Acute epiglottitis and infant conjugate Haemophilus
influenzae type b vaccination in northern Finland. Alho
OP, Jokinen K, Pirila T, et al. Arch.Otolaryngol.Head Neck
Surg. 1995; 121: 898-902. |
|
|
Abstract |
Pertussis vaccines. A progress report. Rabinovich R,
Robbins A. JAMA 1994; 271: 68-69. |
|
|
Abstract |
Diphtheria, tetanus, and pertussis: recommendations for
vaccine use and other preventive measures. Recommendations of
the Immunization Practices Advisory committee (ACIP). MMWR
Recomm.Rep. 1991; 40: 1-28. |
| |
|
Abstract |
Pertussis vaccine--an analysis of benefits, risks and
costs. Koplan JP, Schoenbaum SC, Weinstein MC, et al. N.Engl.J.Med.
1979; 301: 906-911. |
|
4.
Hepatitis A |
|
|
Abstract |
Prevention of hepatitis A through active or passive
immunization: Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR Recomm.Rep.
1996; 45: 1-30. |
|
5.
Hepatitis B |
|
|
Abstract |
Costs and cost-effectiveness of a universal, school-based
hepatitis B vaccination program. Krahn M, Guasparini R,
Sherman M, et al. Am.J.Public Health 1998; 88:
1638-1644. |
|
|
Abstract |
The epidemiology and prophylaxis of hepatitis B in
sub-Saharan Africa: a view from tropical and subtropical
Africa. Kiire CF. Gut 1996; 38 Suppl 2:
S5-12. |
|
|
Abstract |
Importance of perinatal versus horizontal transmission of
hepatitis B virus infection in China. Yao GB. Gut
1996; 38 Suppl 2: S39-S42. |
|
|
Abstract |
Immunisation against hepatitis B in Taiwan. Gust ID. Gut
1996; 38 Suppl 2: S67-S68. |
|
|
Abstract |
Update: recommendations to prevent hepatitis B virus
transmission-- United States. MMWR Morb.Mortal.Wkly.Rep.
1995; 44: 574-575. |
|
6.
Influenza |
|
|
Abstract |
Prevention and control of influenza. Recommendations of the
Advisory Committee on Immunization Practices (ACIP). Bridges
CB, Fukuda K, Cox NJ, et al. MMWR Recomm.Rep. 2001; 50
: 1-44. |
|
|
Abstract |
Does influenza vaccination exacerbate asthma? Analysis of a
large cohort of children with asthma. Vaccine Safety Datalink
Team. Kramarz P, DeStefano F, Gargiullo PM, et al. Arch.Fam.Med.
2000; 9: 617-623. |
|
7.
Measles-Mumps-Rubella |
|
|
Abstract |
The changing epidemiology of rubella in the 1990s: on the
verge of elimination and new challenges for control and
prevention. Reef SE, Frey TK, Theall K, et al. JAMA
2002; 287 : 464-472. |
|
|
Abstract |
Measles, mumps, and rubella--vaccine use and strategies for
elimination of measles, rubella, and congenital rubella
syndrome and control of mumps: recommendations of the Advisory
Committee on Immunization Practices (ACIP). Watson JC,
Hadler SC, Dykewicz CA, et al. MMWR Recomm.Rep. 1998;
47: 1-57. |
|
|
Abstract |
Advances in global measles control and elimination: summary
of the 1997 international meeting. MMWR Recomm.Rep.
1998; 47: 1-23. |
|
|
Abstract |
Congenital rubella syndrome among the Amish--Pennsylvania,
1991-1992. MMWR Morb.Mortal.Wkly.Rep. 1992; 41:
468-6. |
|
|
Abstract |
Mumps in the workplace--Chicago. MMWR
Morb.Mortal.Wkly.Rep. 1988; 37: 533-538. |
|
8.
Polio |
|
|
Abstract |
Cost-effectiveness of incorporating inactivated poliovirus
vaccine into the routine childhood immunization schedule. Miller
MA, Sutter RW, Strebel PM, et al. JAMA 1996; 276:
967-971. |
|
|
Abstract |
Poliomyelitis outbreak in an unvaccinated community in The
Netherlands, 1992-93. Oostvogel PM, van Wijngaarden JK,
van der Avoort HG, et al. Lancet 1994; 344:
665-670. |
|
|
Abstract |
Certification of poliomyelitis eradication--the Americas,
1994. MMWR Morb.Mortal.Wkly.Rep. 1994; 43:
720-722. |
|
9.
Rabies |
|
|
Abstract |
Human rabies prevention--United States, 1999.
Recommendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR Recomm.Rep. 1999; 48:
1-21. |
|
10.
Rotavirus |
|
|
Abstract |
Intussusception among recipients of rotavirus
vaccine--United States, 1998-1999. MMWR
Morb.Mortal.Wkly.Rep. 1999; 48: 577-581. |
|
11.
Smallpox |
|
|
Abstract |
Smallpox: the triumph over the most terrible of the
ministers of death. Barquet N, Domingo P. Ann.Intern.Med.
1997; 127: 635-642. |
|
12.
Streptococcal Pneumonia |
|
|
Abstract |
Prevention of pneumococcal disease: recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR
Recomm.Rep. 1997; 46: 1-24. |
|
|
Abstract |
Recommended childhood immunization schedule--United States,
1995. Centers for Disease Control and Prevention. MMWR
Recomm.Rep. 1995; 44: 1-9. |
|
13.
Tuberculosis |
|
|
Abstract |
The role of BCG vaccine in the prevention and control of
tuberculosis in the United States. A joint statement by the
Advisory Council for the Elimination of Tuberculosis and the
Advisory Committee on Immunization Practices. MMWR
Recomm.Rep. 1996; 45: 1-18. |
|
14.
Varicella |
|
|
Abstract |
Varicella disease after introduction of varicella vaccine
in the United States, 1995-2000. Seward JF, Watson BM,
Peterson CL, et al. JAMA 2002; 287: 606-611. |
|
|
Abstract |
Postlicensure safety surveillance for varicella vaccine. Wise
RP, Salive ME, Braun MM, et al. JAMA 2000; 284:
1271-1279. |
|
|
Abstract |
Varicella-related deaths among children--United States,
1997. MMWR Morb.Mortal.Wkly.Rep. 1998; 47:
365-368. |
|
|
Abstract |
Postlicensure effectiveness of varicella vaccine during an
outbreak in a child care center. Izurieta HS, Strebel PM,
Blake PA. JAMA 1997; 278: 1495-1499. |
|
|
Abstract |
Prevention of varicella: Recommendations of the Advisory
Committee on Immunization Practices (ACIP). CDC. MMWR
Recomm.Rep. 1996; 45: 1-36. |
|
|
Abstract |
Experience and reason: twenty-year follow-up of protective
immunity of the Oka strain live varicella vaccine. Asano
Y, Suga S, Yoshikawa T, et al. Pediatrics 1994; 94:
524-526. |
|
15.
Other/General |
|
|
Abstract |
Addressing parents' concerns: do multiple vaccines
overwhelm or weaken the infant's immune system? Offit PA,
Quarles J, Gerber MA, et al. Pediatrics 2002; 109:
124-129. |
|
|
Abstract |
Individual and community risks of measles and pertussis
associated with personal exemptions to immunization. Feikin
DR, Lezotte DC, Hamman RF, et al. JAMA 2000; 284:
3145-3150. |
|
|
Abstract |
Measles history and atopic diseases: a population-based
cross-sectional study. Paunio M, Heinonen OP, Virtanen M,
et al. JAMA 2000; 283: 343-346. |
|
|
Abstract |
Health consequences of religious and philosophical
exemptions from immunization laws: individual and societal
risk of measles. Salmon DA, Haber M, Gangarosa EJ, et al. JAMA
1999; 282: 47-53. |
|
|
Abstract |
Impact of anti-vaccine movements on pertussis control: the
untold story. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Lancet
1998; 351: 356-361. |
B. Global context of VPDs |
|
|
Abstract |
The changing epidemiology of rubella in the 1990s: on the
verge of elimination and new challenges for control and
prevention. Reef SE, Frey TK, Theall K, et al. JAMA
2002; 287 : 464-472. |
|
|
Abstract |
The synergistic role TQM and reengineering could play in
standardizing the European vaccination policy. Dubois HF. Qual.Manag.Health
Care 2002; 10: 47-57. |
|
|
Abstract |
The changing epidemiology of rubella in the 1990s: on the
verge of elimination and new challenges for control and
prevention. Reef SE, Frey TK, Theall K, et al. JAMA
2002; 287 : 464-472. |
|
|
Abstract |
Measles history and atopic diseases: a population-based
cross-sectional study. Paunio M, Heinonen OP, Virtanen M,
et al. JAMA 2000; 283: 343-346. |
|
|
Abstract |
Impact of vaccines universally recommended for
children--United States, 1990-1998. MMWR
Morb.Mortal.Wkly.Rep. 1999; 48: 243-248. |
|
|
Abstract |
Impact of anti-vaccine movements on pertussis control: the
untold story. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Lancet
1998; 351: 356-361. |
|
|
Abstract |
Advances in global measles control and elimination: summary
of the 1997 international meeting. MMWR Recomm.Rep.
1998; 47: 1-23. |
|
|
Abstract |
Harmonization of vaccination policy. Schaack JC. Biologicals
1997; 25: 243-245. |
|
|
Abstract |
Update: diphtheria epidemic--New Independent States of the Former
Soviet Union, January 1995-March 1996. MMWR
Morb.Mortal.Wkly.Rep. 1996; 45: 693-697. |
|
|
Abstract |
Progress toward elimination of neonatal tetanus--Egypt,
1988-1994. MMWR Morb.Mortal.Wkly.Rep. 1996; 45:
89-92. |
|
|
Abstract |
The epidemiology and prophylaxis of hepatitis B in
sub-Saharan Africa: a view from tropical and subtropical
Africa. Kiire CF. Gut 1996; 38 Suppl 2:
S5-12. |
|
|
Abstract |
Importance of perinatal versus horizontal transmission of
hepatitis B virus infection in China. Yao GB. Gut
1996; 38 Suppl 2: S39-S42. |
|
|
Abstract |
Immunisation against hepatitis B in Taiwan. Gust ID. Gut
1996; 38 Suppl 2: S67-S68. |
|
|
Abstract |
Acute epiglottitis and infant conjugate Haemophilus
influenzae type b vaccination in northern Finland. Alho
OP, Jokinen K, Pirila T, et al. Arch.Otolaryngol.Head Neck
Surg. 1995; 121: 898-902. |
|
|
Abstract |
Poliomyelitis outbreak in an unvaccinated community in The
Netherlands, 1992-93. Oostvogel PM, van Wijngaarden JK,
van der Avoort HG, et al. Lancet 1994; 344:
665-670. |
|
|
Abstract |
Certification of poliomyelitis eradication--the Americas,
1994. MMWR Morb.Mortal.Wkly.Rep. 1994; 43:
720-722. |
|
|
Abstract |
Problems in the choice of combined vaccines for Europe. Plotkin
SA. Biologicals 1994; 22: 411-414. |
